Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Revolution Medicines, Inc. (RVMD)  
$58.17 0.18 (0.31%) as of 4:30 Tue 10/28


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 200,590,000
Market Cap: 11.67(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.13 - $60.6
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Revolution Medicines is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers. Co.'s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which Co. refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target main nodes in the RAS pathway or associated pathways, which Co. refers to as RAS Companion Inhibitors. Co.'s RAS Companion Inhibitors (example, SHP2, mTORC1 and SOS1 inhibitors) are designed primarily for combination treatment strategies involving one or more therapeutic agents, which may include its RAS(ON) Inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,304,347 1,304,347
Total Buy Value $0 $0 $59,999,962 $59,999,962
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 223,701 253,129 404,148 860,013
Total Sell Value $10,336,868 $11,508,567 $19,281,129 $37,901,875
Total People Sold 6 6 7 8
Total Sell Transactions 15 22 41 96
End Date 2025-07-31 2025-04-29 2024-10-29 2023-10-30

   
Records found: 470
  Page 1 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cislini Jeff General Counsel   •       •      –    2025-10-17 4 AS $55.00 $660,000 D/D (12,000) 50,425 1%     
   Cislini Jeff General Counsel   •       •      –    2025-10-17 4 OE $36.57 $438,840 D/D 12,000 62,425     -
   Goldsmith Mark A See Remarks   •       •      –    2025-10-17 4 AS $55.00 $550,000 D/D (10,000) 452,309 1%     
   Goldsmith Mark A See Remarks   •       •      –    2025-10-17 4 OE $1.12 $11,200 D/D 10,000 462,309     -
   Goldsmith Mark A See Remarks   •       •      –    2025-10-16 4 AS $50.47 $504,701 D/D (10,000) 452,309 10%     
   Goldsmith Mark A See Remarks   •       •      –    2025-10-16 4 OE $1.12 $11,200 D/D 10,000 462,309     -
   Kelsey Stephen Michael See Remarks   •       •      –    2025-10-13 4 AS $48.54 $1,213,540 D/D (25,000) 284,047 12%     
   Kelsey Stephen Michael See Remarks   •       •      –    2025-10-13 4 OE $4.73 $118,250 D/D 25,000 309,047     -
   Cislini Jeff General Counsel   •       •      –    2025-09-24 4 AS $44.26 $79,624 D/D (1,799) 50,425 25%     
   Horn Margaret A Chief Operating Officer   •       •      –    2025-09-16 4 AS $45.82 $218,814 D/D (4,775) 145,900 22%     
   Anders Jack Chief Financial Officer   •       •      –    2025-09-16 4 AS $45.82 $106,314 D/D (2,320) 110,994 22%     
   Kelsey Stephen Michael See Remarks   •       •      –    2025-09-16 4 AS $45.82 $245,942 D/D (5,367) 284,047 22%     
   Wei Lin Chief Medical Officer   •       •      –    2025-09-16 4 AS $45.82 $98,982 D/D (2,160) 88,339 22%     
   Cislini Jeff General Counsel   •       •      –    2025-09-16 4 AS $45.82 $85,647 D/D (1,869) 52,224 22%     
   Goldsmith Mark A See Remarks   •       •      –    2025-09-16 4 AS $45.82 $614,558 D/D (13,411) 452,309 22%     
   Kelsey Stephen Michael See Remarks   •       •      –    2025-09-15 4 AS $45.92 $1,149,272 D/D (25,000) 289,414 18%     
   Kelsey Stephen Michael See Remarks   •       •      –    2025-09-15 4 OE $4.73 $118,250 D/D 25,000 314,414     -
   Kelsey Stephen Michael See Remarks   •       •      –    2025-09-11 4 AS $43.58 $4,408,482 D/D (100,000) 289,414 18%     
   Kelsey Stephen Michael See Remarks   •       •      –    2025-09-11 4 OE $4.73 $473,000 D/D 100,000 389,414     -
   Anders Jack Chief Financial Officer   •       •      –    2025-09-03 4 AS $40.17 $210,432 D/D (5,238) 113,314 37%     
   Anders Jack Chief Financial Officer   •       •      –    2025-09-03 4 OE $4.73 $49,917 D/D 5,238 118,552     -
   Anders Jack Chief Financial Officer   •       •      –    2025-09-02 4 AS $40.02 $190,560 D/D (4,762) 113,314 38%     
   Anders Jack Chief Financial Officer   •       •      –    2025-09-02 4 OE $2.68 $16,756 D/D 4,762 118,076     -
   Goldsmith Mark A See Remarks   •       •      –    2025-06-30 4 OE $0.54 $19,980 D/D 37,000 465,720     -
   Kim Lorence H.   •       •      –    2025-06-26 4 A $0.00 $0 D/D 3,142 73,090     -
  470 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us